1 line
3.3 KiB
JSON
1 line
3.3 KiB
JSON
{"Abortion spontaneous": 2.312950445121351, "Abscess": 10.47828900988403, "Adverse event": 2.0845571676533283, "Alanine aminotransferase increased": 4.315551531010428, "Application site erythema": 5.274827850391704, "Aspartate aminotransferase increased": 4.192710698141751, "Ataxia": 3.682963182425097, "Autoimmune hepatitis": 11.16210432686378, "Autoimmune thyroiditis": 6.594795665515045, "Breast cancer": 2.9509869245289586, "Cardiomyopathy": 4.149613964252412, "Cellulitis": 4.31690922074272, "Depressed mood": 2.510332754822995, "Depression": 3.182238101549189, "Device operational issue": 29.42985552102633, "Dilated cardiomyopathy": 6.03127253524514, "Drug delivery system malfunction": 9.141797321708395, "Erysipelas": 5.753397019313024, "Expanded disability status scale score increased": 263.1656190182535, "Gait disturbance": 3.1364576886390454, "Gait inability": 2.088595588605608, "Gamma-glutamyltransferase increased": 8.029269148548016, "Hemiparesis": 3.033009720895796, "Hemiplegia": 2.756704943379932, "Hepatic enzyme increased": 2.4083389078484605, "Hepatic steatosis": 3.333658828091606, "Hepatitis": 3.45065821253789, "Hyperthyroidism": 2.673408447388397, "Incorrect dose administered by device": 15.98675005858739, "Influenza like illness": 5.200479261848722, "Injection site abscess": 192.44242192436116, "Injection site atrophy": 94.60407854944586, "Injection site bruising": 8.995978415991233, "Injection site cellulitis": 88.50121750688037, "Injection site discolouration": 49.09361632465938, "Injection site erythema": 6.455033157458272, "Injection site haematoma": 3.429145212862429, "Injection site haemorrhage": 7.617306709067428, "Injection site induration": 19.87274297123187, "Injection site infection": 69.9395905386055, "Injection site inflammation": 3.108856076207028, "Injection site mass": 14.03604619650286, "Injection site necrosis": 242.46496516396616, "Injection site nodule": 16.28219088088887, "Injection site oedema": 5.977001823109292, "Injection site pain": 3.424876176844528, "Injection site rash": 8.279254956593867, "Injection site reaction": 11.620657051754536, "Injection site ulcer": 150.39654939070428, "Jaundice": 2.5575392497411418, "Leukopenia": 2.845303757291461, "Liver function test increased": 10.74301469681734, "Lymphocyte count decreased": 6.762588910126118, "Lymphopenia": 3.0272881448863496, "Mobility decreased": 2.501567399333673, "Multiple sclerosis": 69.19632833547284, "Multiple sclerosis relapse": 83.12951191182691, "Muscle rigidity": 2.472485330421788, "Muscle spasticity": 12.427193403691309, "Muscular weakness": 3.045618896583388, "Nephrotic syndrome": 4.276446191708813, "Neuromyelitis optica spectrum disorder": 36.07455045600889, "No adverse event": 2.098320871672575, "Optic neuritis": 15.885276611415652, "Panniculitis": 13.03687385137447, "Paralysis": 2.8328005403394143, "Paraparesis": 13.538559077179602, "Product dose omission issue": 3.6202939883059706, "Rash macular": 2.0246893428786588, "Raynaud's phenomenon": 6.364718809565585, "Secondary progressive multiple sclerosis": 75.64917814063908, "Sensory disturbance": 2.8814928679209904, "Skin necrosis": 29.481193262851587, "Skin reaction": 5.756386793338486, "Skin ulcer": 2.697398202199367, "Thrombotic microangiopathy": 10.124776492912403, "Transaminases increased": 3.9775351010221183, "Urinary incontinence": 2.035830871649755} |